SCOPUS 정보 검색 플랫폼

Nature Clinical Practice Oncology

Volumn 5, Issue 2, 2008, Pages 76-77

Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer: Commentary

(1) Boccardo, Francesco a

a UNIVERSITY OF GENOA (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ESTROGEN RECEPTOR; TAMOXIFEN;

BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SHORT SURVEY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WOMEN'S HEALTH;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; NITRILES; POSTMENOPAUSE; PROSPECTIVE STUDIES; SURVIVORS; TAMOXIFEN; TREATMENT OUTCOME; TRIAZOLES;

EID: 38849089289 PISSN: 17434254 EISSN: 17434262 Source Type: Journal
DOI: 10.1038/ncponc1015 Document Type: Short Survey

Times cited : (5)

References (5)

1
- 33846545851
- Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): A randomised controlled trial
- Coombes RC et al. (2007) Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): A randomised controlled trial. Lancet 369: 559-570
- (2007) Lancet , vol.369 , pp. 559-570
- Coombes, R.C.¹

2
- 23444446523
- Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial
- Jakesz R et al. (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366: 455-462
- (2005) Lancet , vol.366 , pp. 455-462
- Jakesz, R.¹

3
- 24644519961
- Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial
- Boccardo F et al. (2005) Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial. J Clin Oncol 23: 5138-5147
- (2005) J Clin Oncol , vol.23 , pp. 5138-5147
- Boccardo, F.¹

4
- 33751321384
- Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: A meta-analysis
- Jonat W et al. (2006) Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: A meta-analysis. Lancet Oncol 7: 991-996
- (2006) Lancet Oncol , vol.7 , pp. 991-996
- Jonat, W.¹

5
- 33846975537
- Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: Pooled analysis of two consecutive trials
- Boccardo F et al. (2007) Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: Pooled analysis of two consecutive trials. Cancer 109: 1060-1067
- (2007) Cancer , vol.109 , pp. 1060-1067
- Boccardo, F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.